Magda Marquet - 11 Jun 2024 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role: Director
Signature: /s/ Ilya Rachman as Attorney-In-Fact for Magda Marquet
Issuer symbol: IMMX
Transactions as of: 11 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 21 Jun 2024, 17:45:17 UTC
Previous filing: 20 May 2024
Next filing: 18 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMMX	Common Stock						46,092	11 Jun 2024	Direct
holding	IMMX	Common Stock						20,000	11 Jun 2024	Via ALMA Life Sciences, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMMX	Stock Option (Right to Buy)	Award	$0	+33,000		$0.000000	33,000	11 Jun 2024	Common Stock	33,000	$2.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Remarks:

See Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the Reporting Person on December 15, 2021.